
    
      Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for
      catheter ablations of complex arrhythmias from three continents - Asia, Europe and North
      America - are registered in a common database. The investigators exclude patients who were
      lost to follow up in the outpatient clinic.
    
  